References
- Paur H, Wright PT, Sikkel MB,
Tranter MH, Mansfield C, O’Gara P, et al. (2012). High levels of
circulating epinephrine trigger apical cardiodepression in a
b2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo
cardiomyopathy. Circulation 126:697–706.
- Adzika GK, Machuki JO, Shang W, Hou H, Ma T, Wu L, et al. (2019).
Pathological cardiac hypertrophy: the synergy of adenylyl cyclases
inhibition in cardiac and immune cells during chronic catecholamine
stress. J. Mol. Med. 97:897–907.
- Xie M, Burchfield JS, Hill JA (2013). Pathological ventricular
remodeling: therapies: part 2 of 2. Circulation 128:1021–1030.
- Hartupee J, Mann DL (2016). Role of inflammatory cells in fibroblast
activation. J Mol Cell. Cardiol. 93:143–148.
- Kong P, Christia P, Frangogiannis NG (2014). The pathogenesis of
cardiac fibrosis. Cell. Mol. Life. Sci. 71:549–574.
- Epelman S, Lavine KJ, Beaudin AE, Sojka DK, Carrero JA, Calderon B, et
al. (2014). Embryonic and adult-derived resident cardiac macrophages
are maintained through distinct mechanisms at steady state and during
inflammation. Immunity 40:91–104.
- Heidt T, Courties G, Dutta P, Sager HB, Sebas M, Iwamoto Y, et al
(2014). Differential contribution of monocytes to heart macrophages in
steady-state and after myocardial infarction. Circ. Res. 115:284–295.
- Hulsmans M, Sam F, Nahrendorf M (2016). Monocyte and macrophage
contributions to cardiac remodeling. J. Mol. Cell. Cardiol.
93:149–155.
- Laukova M, Vargovic P, Rokytova I, Manz G, Kvetnansky R (2018).
Repeated Stress Exaggerates Lipopolysaccharide-Induced Inflammatory
Response in the Rat Spleen. Cell Mol Neurobiol 38:195–208.
- Li Y, Chen L, Kass RS, Dessauer CW (2012). The A-kinase anchoring
protein Yotiao facilitates complex formation between adenylyl cyclase
type 9 and the IKs potassium channel in heart. J. Biol. Chem.
287:29815–29824.
- Kipanyula MJ, Woodhoo A, Rahman M, Payne D, Jessen KR, Mirsky R
(2013). Calcineurin-nuclear factor of activated T cells regulation of
Krox-20 expression in Schwann cells requires elevation of
intracellular cyclic AMP. J. Neurosci. Res. 91:105–115.
- Pereira L, Rehmann H, Lao DH, Erickson JR, Bossuyt J, Chen J, et al.
(2015). Novel Epac fluorescent ligand reveals distinct Epac1 vs. Epac2
distribution and function in cardiomyocytes. Proc. Natl. Acad. Sci.
USA 112:3991–3996.
- Murphy JG, Crosby KC, Dittmer PJ, Sather WA, Dell’Acqua ML (2019)
AKAP79/150 recruits the transcription factor NFAT to regulate
signaling to the nucleus by neuronal L-type
Ca2+ channels. Mol Biol Cell 30:1743–1756.
- Gerlo S, Kooijman, R, Beck IM, Kolmus, K, Spooren A, Haegeman, G
(2011). Cyclic AMP: a selective modulator of NF-κB action. Cell.
Mol. Life Sci. 68, 3823–3841.
- Patial S, Shahi S, Saini Y, Lee T, Packiriswamy N, Appledorn DM, et
al. (2011). G-protein coupled receptor kinase 5 mediates
lipopolysaccharide-induced NFκB activation in primary macrophages and
modulates inflammation in vivo in mice. J. Cell. Physiol.
226:1323–1333.
- Gravning J, Ahmed MS, Qvigstad E, Krobert K, Edvardsen T, Moe IT, et
al. (2013). Connective tissue growth factor/CCN2 attenuates-adrenergic
receptor responsiveness and cardiotoxicity by induction of G
protein-coupled receptor kinase-5 in cardiomyocytes. Mol. Pharmacol.
84:372–383.
- Hullmann JE, Grisanti LA, Makarewich CA, Gao E, Gold JI, Chuprun JK,
et al. (2014). GRK5-mediated exacerbation of pathological cardiac
hypertrophy involves facilitation of nuclear NFAT activity. Circ. Res.
115:976–985.
- Quan MY, Song XJ, Liu HJ, Deng XH, Hou HQ, Chen LP, et al. (2019).
Amlexanox attenuates experimental autoimmune encephalomyelitis by
inhibiting dendritic cell maturation and reprogramming effector and
regulatory T cell responses. J Neuroinflammation 16:52.
- Jia D, Jiang H, Weng X, Wu J, Bai P, Yang W, et al. (2019).
Interleukin35 promotes macrophage survival and improves wound healing
after myocardial infarction in mice. Circ. Res.
124: 1323-1336.
- Ray A, Dittel BN (2010). Isolation of Mouse Peritoneal Cavity Cells.
J. Vis. Exp. 28:1488.
- Gold JI, Gao E, Shang X, Premont RT, Koch WJ (2013). Determining the
absolute requirement of g protein-coupled receptor kinase 5 for
pathological cardiac hypertrophy: Short communication. Circ. Res.
111:1048-1053.
- Lieu M, Koch WJ (2019). GRK2 and GRK5 as therapeutic targets and their
role in maladaptive and pathological cardiac hypertrophy. Expert.
Opin. Ther. Targets 23:201–214.
- Kim MH, Gorouhi F, Ramirez S, Granick JL, Byrne BA, Soulika AM, et al.
(2014). Catecholamine stress alters neutrophil trafficking and impairs
wound healing by β2 adrenergic receptor mediated upregulation of IL-6.
J. Invest. Dermatol. 134:809–817.
- Wu YS, Chen CC, Chien CL, Lai HL, Jiang ST, Chen YC, et al. (2017).
The type VI adenylyl cyclase protects cardiomyocytes from β-adrenergic
stress by a PKA/STAT3-dependent pathway. J. Biomed. Sci.24 :68.
- Tang T, Gao MH, Lai NC, Firth AL, Takahashi T, Guo T, et al. (2008).
Adenylyl cyclase type 6 deletion decreases left ventricular function
via impaired calcium handling. Circulation 117:61–69.
- Raker VK, Becker C, Steinbrink K (2016) The cAMP pathway as
therapeutic target in autoimmune and inflammatory diseases. Front.
Immunol. 7 :123.
- Premont RT, Gainetdinov RR (2007). Physiological roles of G
protein-coupled receptor kinases and arrestins. Annu. Rev. Physiol.
69:511–534.
- Martini JS, Raake P, Vinge LE, DeGeorge BR Jr, Chuprun JK, Harris DM,
et al. (2008) Uncovering G protein-coupled receptor kinase-5 as a
histone deacetylase kinase in the nucleus of cardiomyocytes. Proc.
Natl. Acad. Sci. USA 105:12457-12462.
- Islam KN, Bae JW, Gao E, Koch WJ (2013). Regulation of nuclear factor
κB (NF-κB) in the nucleus of cardiomyocytes by G protein-coupled
receptor kinase 5 (GRK5). J. Biol. Chem. 288:35683–35689.
- Sorriento D, Santulli G, Ciccarelli M, Maione AS, Illario M, Trimarco
B, et al. (2018). The Amino-Terminal Domain of GRK5 Inhibits Cardiac
Hypertrophy through the Regulation of Calcium-Calmodulin Dependent
Transcription Factors. Int. J. Mol. Sci. 19:861.
- Zimmer A, Bagchi AK, Vinayak K, Bello-Klein A, Singal PK (2019).
Innate immune response in the pathogenesis of heart failure in
survivors of myocardial infarction. Am J. Physiol. Heart. Circ.
Physiol. 316:H435–H445.
- Liu YZ, Wang YX, Jiang CL (2017). Inflammation: The Common Pathway of
Stress-Related Diseases. Front. Hum. Neurosci. 11:316.
- Maydych, V (2019). The Interplay Between Stress, Inflammation, and
Emotional Attention: Relevance for Depression. Front. Neurosci.13 :384.
- Packiriswamy N, Parameswaran N (2015). G-protein-coupled receptor
kinases in inflammation and disease. Genes Immun. 16:367-377.
- Wehbi VL, Taskén K (2016). Molecular Mechanisms for cAMP-Mediated
Immunoregulation in T cells - Role of Anchored Protein Kinase A
Signaling Units. Front. Immunol. 7:222.
- Bopp T, Dehzad N, Reuter S, Klein M, Ullrich N, Stassen M, et al.
(2009). Inhibition of cAMP degradation improves regulatory T
cell-mediated suppression. J. Immunol. 182:4017–4024.
- Homan KT, Wu E, Cannavo A, Koch WJ, Tesmer JJ (2014). Identification
and characterization of amlexanox as a G protein-coupled receptor
kinase 5 inhibitor. Molecules 19:16937–16949.